Non-invasive treatment for diabetic neuropathy shows promise

Main Category: Diabetes
Article Date: 05 Jan 2004 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)


A new, non-invasive device that uses near-infrared light to increase blood flow in diabetic peripheral neuropathy (DPN) has shown promising results in early clinical trials.

Treatment with the Anodyne Therapy System (ATS) appears to restores sensation, reduce pain, and improve balance in patients with diabetic peripheral neuropathy (DPN), according to a report published in the January issue of Diabetes Care.

ATS is thought to increase blood flow by dilating arteries and veins.

The auhors assessed the outcomes of 27 patients with DPN who were treated with placebo or active ATS for 2 weeks and then active therapy for 2 more weeks three times a week.

The study group included 9 patients who were insensitive to 5.07 and 6.65 test filaments and 18 who were only insensitive to the 5.07 filament.

In the group with milder sensory impairment, both 6 and 12 weeks of ATS were associated with a significant drop in the number of insensate sites. In contrast, no sensory improvements were seen with sham therapy.

ATS therapy was also tied to a reduction in neuropathic symptoms scores and with a fall in visual analog pain scores and the percentage of patients with substantial balance problems decreased from 90% to 17% with ATS.

But in the patients insensate to both test filaments, ATS did not produce significant improvements in sensation, neuropathic symptoms, or pain.

Although the results are 'encouraging,' the authors conclude 'more discreet quantitative sensory tests would be helpful in determining the exact degree of sensory improvement experienced after the administration of ATS treatments.'

Reference: Leonard D, Farooqi M and Myers S (2003) Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy: A double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment Diabetes Care 27 (1) 168-172

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
n.p. "Non-invasive treatment for diabetic neuropathy shows promise." Medical News Today. MediLexicon, Intl., 5 Jan. 2004. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/5186.php>

APA
n.p. (2004, January 5). "Non-invasive treatment for diabetic neuropathy shows promise." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/5186.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »